Tenderwize
Wróć do wyszukiwania

Open-House Rabatt Contracts for Follitropin beta

Techniker Krankenkasse·Hamburg, Germany·Deadline Apr 30, 2027 · 248 days left·Open·Supplies
Zarejestruj się, aby zapisaćOpen documents
Oryginalny tytuł ogłoszenia

Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2025-04 - Follitropin beta

52/100

Ocena szansy

Needs reviewMedium complexity
SuppliesOpen
Skąd ta ocena?

Szansa

52 / 100

Złożoność

58 / 100

Czynniki ryzyka

Electronic submission through the portal is not allowed, despite portal-based communication; submission must follow the...

Although entry is possible at any time during the contract period, the notice states that timely submission by the 3rd...

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • Supplies contract
  • 1 lot
  • Duration until Apr 2027
  • Conclude pharmaceutical rebate contracts for the active substance Follitropin beta.
  • Provide supplies under an Open-House procedure with standard, non-negotiated terms.
Pokaż pełne podsumowanie

This is a German Open-House supply arrangement for pharmaceutical products, specifically Rabattverträge for the active substance Follitropin beta. The contracting buyers are Techniker Krankenkasse as lead buyer, with HEK and hkk as participating buyers. It is not an exclusive contract: all suitable pharmaceutical companies may join during the contract period under uniform terms, with no individual negotiations. The contract runs for up to 24 months from 01.05.2025 and ends no later than 30.04.2027. Electronic submission via the portal is not allowed; contracts must be submitted by email with qualified electronic signature or by post, with details in the participation and contract documents.

Ryzyka

Electronic submission through the portal is not allowed, despite portal-based communication; submission must follow the...

Although entry is possible at any time during the contract period, the notice states that timely submission by the 3rd...

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • Bidder must be a pharmaceutical entrepreneur within the meaning of Section 4(18) AMG for the offered medicinal products.
  • Bidder must have its seat in Germany, another EU Member State, or another EEA state.
  • Bidder must have a valid marketing authorisation for the relevant medicinal product(s), or otherwise be legally entitled to place them on the market in its own name.

Kryteria udzielenia

Lot 1

Other criterion: participation and suitability requirements; no numeric weight stated.

Zamawiający

Lokalizacja

Hamburg, DEU

Identyfikator

992-80116-93

Działalność

Health

Części (1)

LOT-0001

Open-House Rabatt Contracts for Follitropin beta

Open-House supply arrangement for pharmaceutical rebate contracts under Section 130a(8) SGB V for the active ingredient Follitropin beta. Scope is nationwide in Germany. The lot information comes from the structured notice and XML notice.

SuppliesEU fundedElectronic submission

Lokalizacja

DE600, Germany

Czas trwania

Apr 2025 - Apr 2027

Kategoria

Pharmaceutical products

Kryteria udzielenia

Other criterion: participation and suitability requirements; no numeric weight stated.

Termin

Deadline Apr 30, 2027

Szczegóły zamówienia

Data publikacji
16 Mar 2025
Języki
German

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
171456-2025

Dokumenty (1)

Dokument zamówienia 1

Podobne przetargi

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3